SUBSCRIBE
SUBSCRIBE

Phase II

Business
BioSpace Global Roundup, Sept. 3
Biopharma and life science companies from across the globe provide updates on their pipelines and businesses.
September 2, 2020
 · 
7 min read
 · 
Alex Keown
Policy
Biopharma Update on the Novel Coronavirus: September 2
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 2, 2020.
September 1, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Drug Development
Vir Bio and GSK Join the Race for a COVID-19 Monoclonal Antibody Therapy
Vir Biotechnology and GlaxoSmithKline dosed the first patient last week in a Phase II/III clinical trial of VIR-7831, a fully human monoclonal antibody against COVID-19.
August 31, 2020
 · 
3 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: August 31
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 31, 2020.
August 31, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Drug Development
Clinical Catch-Up: August 24-28
As August wraps up, there were still clinical trial announcements, although fewer than earlier this summer. Here’s a look.
August 31, 2020
 · 
5 min read
 · 
Mark Terry
Business
Biopharma Update on the Novel Coronavirus: August 28
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 28, 2020.
August 28, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Drug Development
Takeda and Ovid’s Epilepsy Drug Sees Positive Results in Phase II Trial
Takeda Pharmaceutical and Ovid Therapeutics announced on Tuesday that they have gathered positive data from their Phase II ELEKTRA study of soticlestat in children with Dravet Syndrome (DS) or Lennox-Gastaut Syndrome (LGS).
August 26, 2020
 · 
3 min read
 · 
Krystle Vermes
Policy
Biopharma Update on the Novel Coronavirus: August 26
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 26, 2020.
August 25, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: August 24
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 24, 2020.
August 24, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Drug Development
Clinical Catch-Up: August 17-21
It was a relatively quiet week for clinical trial news. Here’s a look.
August 21, 2020
 · 
5 min read
 · 
Mark Terry
Load More
PRESS RELEASES
Drug Development
ORYZON Announces U.S. FDA Clearance of CTEP-CRADA Phase I/II Clinical Trial Sponsored by NCI for Iadademstat Plus Immune Checkpoint Inhibitors in 1L Extensive Stage Small Cell Lung Cancer
April 8, 2024
 · 
7 min read
Business
Psyence Biomed Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
April 8, 2024
 · 
8 min read
Drug Development
IntelGenx Announces First Parkinson’s Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ‘MONTPARK’ Clinical Trial
April 8, 2024
 · 
5 min read
Drug Development
Delta-Fly Pharma Inc.: Notice of Authorization to Conduct the Phase I/II Study of DFP-10917 combined with Venetoclax
April 8, 2024
 · 
1 min read
Drug Development
Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency (PXE) and ENPP1 Deficiency
April 8, 2024
 · 
16 min read
Drug Development
Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin Cancers Presented During Oral Presentation at the AACR 2024 Annual Meeting
April 7, 2024
 · 
5 min read
Drug Development
Geneos Therapeutics Announces Positive Phase 1/2 Data for GT-30 Trial of Personalized Therapeutic Cancer Vaccine
April 7, 2024
 · 
6 min read
Drug Development
Linvoseltamab Pivotal Data Presented at AACR Reinforce High Response Rate that Deepens Over Time in Patients with Heavily Pre-Treated Multiple Myeloma
April 7, 2024
 · 
13 min read
Drug Development
Arrowhead Pharmaceuticals Announces New Phase 2 Data of Plozasiran Published in JAMA Cardiology and Presented at American College of Cardiology 73rd Annual Scientific Session & Expo
April 7, 2024
 · 
10 min read
Drug Development
Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension
April 7, 2024
 · 
14 min read
Drug Development
Ocular Therapeutix™ Announces Positive Phase 2 PAXTRAVA™ Glaucoma Data at the American Society of Cataract and Refractive Surgery 2024 Annual Meeting
April 6, 2024
 · 
12 min read
Drug Development
Participants in Nigeria Vaccinated in First-Ever Phase 2 Lassa Fever Vaccine Clinical Trial, Sponsored by IAVI
April 4, 2024
 · 
9 min read
Drug Development
eFFECTOR Therapeutics Announces Topline Results of Phase 2 KICKSTART Trial of Tomivosertib Combined with Pembrolizumab in Non-Small Cell Lung Cancer
April 4, 2024
 · 
6 min read
Drug Development
Rigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia & Lymphoma
April 4, 2024
 · 
11 min read
Drug Development
Candel Therapeutics Announces Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer
April 4, 2024
 · 
11 min read
Business
CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK
April 4, 2024
 · 
7 min read
Drug Development
Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning
April 4, 2024
 · 
6 min read
Drug Development
MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
April 3, 2024
 · 
8 min read
Drug Development
Awakn Life Sciences Announces Launch of Licensing Partnership Agreement with Oklahoma Based Clinic
April 3, 2024
 · 
8 min read
Drug Development
Phase 1/2 Interim Data on Moderna’s mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia, Published in Nature
April 3, 2024
 · 
6 min read
Load More